Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareteqASX:CTQ +9.09% EV-to-EBIT is -10.93 as of Jul. 25, 2026. The stock has 6 warning signs investors should review. Among 469 Healthcare Providers & Services companies, Careteq ranks worse than 213219.4% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Careteq's Enterprise Value is A$10.12 Mil.
Careteq's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.93 Mil. Therefore, Careteq's EV-to-EBIT for today is -10.93.
The historical rank and industry rank for Careteq's EV-to-EBIT or its related term are showing as below:
ASX:CTQ'
s EV-to-EBIT Range Over the Past 10 Years
Min: -70.39 Med: -2.06 Max: -0.05
Current: -10.93
During the past 5 years, the highest EV-to-EBIT of Careteq was -0.05. The lowest was -70.39. And the median was -2.06.
ASX:CTQ's EV-to-EBIT is ranked worse than 100% of 469
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs ASX:CTQ: -10.93
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Careteq's Enterprise Value for the quarter that ended in Dec. 2025 was A$1.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Careteq's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careteq EV-to-EBIT Related Terms
Careteq EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Careteq's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Careteq's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careteq EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Careteq's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Careteq's EV-to-EBIT falls into.
Careteq's current Enterprise Value is A$10.12 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Careteq's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careteq (ASX:CTQ) has a EV-to-EBIT of -10.93 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Careteq and its competitors. According to the industry distribution chart, Careteq ranks #999999 out of 469 companies in the Healthcare Providers & Services industry.
Is Careteq's EV-to-EBIT too high?
Careteq's current EV-to-EBIT is -10.93. Based on the distribution chart, Careteq ranks #999999 out of 469 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Careteq's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Careteq ranks #999999 out of 469 companies for EV-to-EBIT. This places Careteq in the lower half of its industry. The industry median EV-to-EBIT is 15.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Careteq and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careteq's current EV-to-EBIT is -10.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 20% above its estimated fair value. The current EV-to-EBIT is -10.93. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current EV-to-EBIT is -10.93 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CTQ has been successfully added to your 
